Clinical Evidence | The Validation Layer of the XIHE Science Platform | Articles

1 evidence brief in this topic. Sorted by publication date, newest first.

PKU Third Hospital Study: 78.3% Reported Outcome and What Was Measured

PKU Third Hospital Study: 78.3% Reported Outcome and What Was Measured

Review the PKU Third Hospital study summary cited by XIHE: a reported 78.3% comfort-related outcome, a 64.9% microcirculation marker change, the 8-week protocol context, and what those numbers do and do not prove.

July 16, 2026 |Clinical Evidence Hub Read

Explore Related Topics

Cellular Energy | ATP, Biological Cost, and the Energy Economics of Living What Is Far Infrared Graphene? Technology, Emitter Architecture, and Evaluation Fatigue | Low Energy, Recovery Debt, and System Load Healthy Aging | Resilience, Recovery, and Long-Term Function Inflammation | Acute Response, Chronic Load, and Resolution Metabolism | ATP, Fuel Conversion, and Cellular Work Microcirculation | The Delivery Network of Cellular Energy Mitochondria | The Energy Conversion Engine of Cellular Energy
Back to Clinical Evidence | The Validation Layer of the XIHE Science Platform